Jesse Wu - 31 Oct 2021 Form 4 Insider Report for LianBio (LIANY)

Role
Director
Signature
By: /s/ Angela Chen, Attorney-in-Fact
Issuer symbol
LIANY
Transactions as of
31 Oct 2021
Net transactions value
$0
Form type
4
Filing time
01 Nov 2021, 19:21:50 UTC
Previous filing
29 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIAN Stock Option (Right to Buy) Award $0 -72,600 -50% $0.000000 72,600 31 Oct 2021 Ordinary Shares 72,600 $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36 of the shares underlying the option vested and became exercisable on October 31, 2021; the remainder shall vest and become exercisable in 35 equal monthly installments such that the option shall be fully vested on October 31, 2024, subject to the Reporting Person providing continuous service to the Issuer on each such date.